COTN

The ticker the user supplied references Cembra Money Bank, but the underlying data package points unambiguously to Comet Holding AG, the Swiss manufacturer of plasma control components and industrial X-ray systems headquartered in Flamatt. This analysis follows the data. Comet is a CHF 2.2 billion market cap specialist whose name almost never appears in consumer-facing discourse, yet whose RF generators and vacuum capacitors sit inside a meaningful share of the etch and deposition chambers used to manufacture DRAM, NAND, and high-bandwidth memory worldwide. The company does not make chips. It makes the equipment that tunes the electromagnetic field inside the machines that make chips.

That distinction matters because it places Comet at the third tier of the semiconductor value chain, below the fabs and below the wafer fabrication equipment OEMs, in the component layer where structural dependencies are densest and cyclical amplitude is greatest. The 2025 numbers tell the story with unusual clarity. Revenue of CHF 457 million was up only 2.6% year over year, but gross margin compressed to 38.0% from 43.4% in 2024, net income collapsed from CHF 35.1 million to CHF 12.2 million, and EPS fell from 4.52 to 1.57. The stock trades at 143 times trailing earnings. The market is not pricing 2025. It is pricing a cycle recovery that analyst consensus expects to lift revenue to CHF 534 million in 2026, CHF 632 million in 2027, and EPS toward 15 by 2028.

The central analytical observation is this: Comet does not control its own cycle. Its revenue is a derivative of memory capex decisions taken in the boardrooms of Samsung, SK Hynix, Micron, and a handful of Chinese fabs, filtered through the order books of Lam Research and Applied Materials. What Comet owns is the qualification. What it does not own is the timing. The question for the analyst is whether the qualification is durable enough to make the dependency asymmetrically profitable when the cycle turns.